Blog

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula – EurekAlert (press release)

Mesenchymal stem cells offer novel treatment approach for Crohn's disease fistula
EurekAlert (press release)
14, 2017–A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn's disease-related fistula can be a safe and effective addition to surgery.
Mesenchymal Stem Cells Market Regulations and Competitive Landscape Outlook to 2025Digital Journal



all 2 news articles »

2017-09-14 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.